Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Investigation|January 27, 2007
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomasDanan Li, Hongbin Ji, Sara Zaghlul, et al.
Nature Communications|January 20, 2022
Author Correction: Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinomaXiangkun Han, Fuming Li, Zhaoyuan Fang, et al.
Oncotargets and Therapy|August 26, 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaHaichuan Hu, Yunjian Pan, Yuan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancerRui Wang, Haichuan Hu, Yunjian Pan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 23, 2025
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung CancerYueren Yan, Ning Wang, Bowen Xing, et al.
Cell Discovery|July 28, 2016
Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancerYuanhui Jia, Pishun Li, Lan Fang, et al.
Nature Communications|February 18, 2014
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinomaXiangkun Han, Fuming Li, Zhaoyuan Fang, et al.
Nature Cancer|April 22, 2022
Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancerChenchen Guo, Ruijie Wan, Yayi He, et al.
Nature Communications|October 27, 2019
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progressionYulin Shi, Songqing Fan, Mengge Wu, et al.
Cell|May 27, 2026
Farnesylation-driven KRAS phase separation promotes colon tumor growthXingwen Wang, Yi Zhang, Minqiao Lu, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Investigation|January 27, 2007
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomasDanan Li, Hongbin Ji, Sara Zaghlul, et al.
Nature Communications|January 20, 2022
Author Correction: Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinomaXiangkun Han, Fuming Li, Zhaoyuan Fang, et al.
Oncotargets and Therapy|August 26, 2014
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaHaichuan Hu, Yunjian Pan, Yuan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancerRui Wang, Haichuan Hu, Yunjian Pan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 23, 2025
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung CancerYueren Yan, Ning Wang, Bowen Xing, et al.
Cell Discovery|July 28, 2016
Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancerYuanhui Jia, Pishun Li, Lan Fang, et al.
Nature Communications|February 18, 2014
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinomaXiangkun Han, Fuming Li, Zhaoyuan Fang, et al.
Nature Cancer|April 22, 2022
Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancerChenchen Guo, Ruijie Wan, Yayi He, et al.
Nature Communications|October 27, 2019
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progressionYulin Shi, Songqing Fan, Mengge Wu, et al.
Cell|May 27, 2026
Farnesylation-driven KRAS phase separation promotes colon tumor growthXingwen Wang, Yi Zhang, Minqiao Lu, et al.
Pageof 22